First Trust Nasdaq Pharmaceuticals ETF (FTXH)
NASDAQ: FTXH · Real-Time Price · USD
33.44
-0.02 (-0.07%)
Jan 16, 2026, 9:30 AM EST - Market open
FTXH Holdings Information
FTXH is an equity ETF with a total of 51 individual holdings. The top holdings are Merck & Co. stock at 7.82%, Johnson & Johnson at 7.33%, Bristol-Myers Squibb Company at 7.21%, AbbVie at 6.38%, and Pfizer at 6.18%.
Total Holdings
51
Top 10 Percentage
55.49%
Asset Class
Equity
ETF Category
Health
Assets
21.70M
PE Ratio
17.97
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MRK | Merck & Co., Inc. | 7.82% |
| 2 | JNJ | Johnson & Johnson | 7.33% |
| 3 | BMY | Bristol-Myers Squibb Company | 7.21% |
| 4 | ABBV | AbbVie Inc. | 6.38% |
| 5 | PFE | Pfizer Inc. | 6.18% |
| 6 | LLY | Eli Lilly and Company | 4.47% |
| 7 | CAH | Cardinal Health, Inc. | 4.26% |
| 8 | BIIB | Biogen Inc. | 4.02% |
| 9 | REGN | Regeneron Pharmaceuticals, Inc. | 3.97% |
| 10 | VTRS | Viatris Inc. | 3.85% |
| 11 | VRTX | Vertex Pharmaceuticals Incorporated | 3.54% |
| 12 | AMGN | Amgen Inc. | 3.43% |
| 13 | GILD | Gilead Sciences, Inc. | 3.28% |
| 14 | UTHR | United Therapeutics Corporation | 3.24% |
| 15 | ZTS | Zoetis Inc. | 2.42% |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 2.32% |
| 17 | ILMN | Illumina, Inc. | 2.23% |
| 18 | PTCT | PTC Therapeutics, Inc. | 1.64% |
| 19 | CRL | Charles River Laboratories International, Inc. | 1.63% |
| 20 | INCY | Incyte Corporation | 1.59% |
| 21 | EXEL | Exelixis, Inc. | 1.34% |
| 22 | MEDP | Medpace Holdings, Inc. | 1.23% |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.23% |
| 24 | ELAN | Elanco Animal Health Incorporated | 1.15% |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 0.98% |
As of Jan 14, 2026